EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitLeitlinieOpen Access · CC BY-NC-ND 4.0

Postpartum contraception: A matter of guidelines

Giovanni Grandi iD, Maria C Del Savio, Alice Tassi, Fabio Facchinetti

International Journal of Gynecology & Obstetrics · 2024

DOI: 10.1002/ijgo.14928 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Gynecology & Obstetrics, 2024. Verfasst von Giovanni Grandi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical and Surgical Sciences for Mother, Child and Adult, University of Modena and Reggio Emilia, Azienda Ospedaliero Universitaria Po…. Hauptthemen laut MEDLINE: Contraception, Intrauterine Devices. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The postpartum period is the perfect time to access family planning services. WHO guidelines contraindicate combined hormonal contraceptives postpartum in breastfeeding patients between 6 weeks and 6 months after delivery (Medical Eligibility Criteria category 3). On the contrary, the Faculty of Sexual and Reproductive Healthcare and the Centers for Disease Control and Prevention guidelines do not contraindicate their use in women who breastfeed from 6 weeks to 6 months postpartum. New combined hormonal contraceptives with natural estrogens have never been studied in this setting. Guidelines agree on the prescription of the progestin‐only pill postpartum in non‐breastfeeding women (category 1). Differences are found in women who breastfeed. In non‐breastfeeding women, an implant is considered safe (category 1) by all guidelines, without any distinction in time. Regarding postpartum breastfeeding women, the guidelines for implants give quite different indications but are still permissive. Intrauterine devices are viable options for postpartum contraception but guidelines give different indications about the timing of insertion. Postplacental intrauterine device placement can reduce the subsequent unintended pregnancy rate, particularly in settings at greatest risk of not having recommended postpartum controls. However, it has yet to be understood whether this approach can really have an advantage in high‐income countries. Postpartum contraception is not a ‘matter of guidelines’: it is the best customization for each woman, as early as possible but at the ideal timing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ContraceptionIntrauterine DevicesPregnancyHumansFemalePostpartum PeriodReproductionFamily Planning ServicesContraceptive Agents

Stichwörter der Autor:innen

breastfeedingcontraceptionintrauterine devicelong-acting reversible contraceptionpostpartum periodsubcutaneous implantthrombosis

Substanzen

Contraceptive Agents

Autor:innen und Institutionen

  • Department of Medical and Surgical Sciences for Mother, Child and Adult, University of Modena and Reggio Emilia, Azienda Ospedaliero Universitaria Policlinico, Modena, Italy.
  • Clinic of Obstetrics and Gynecology, DAME, University Hospital of Udine, Udine, Italy.

ORCID-Profile: Giovanni Grandi

Zitieren

APA

Grandi, G., Del Savio, M. C., Tassi, A., & Facchinetti, F. (2024). Postpartum contraception: A matter of guidelines. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.14928

Vancouver

Grandi G, Del Savio MC, Tassi A, Facchinetti F. Postpartum contraception: A matter of guidelines. International Journal of Gynecology & Obstetrics. 2024. doi:10.1002/ijgo.14928

BibTeX
@article{Grandi2024,
  author = {Grandi, Giovanni and Del Savio, Maria C and Tassi, Alice and Facchinetti, Fabio},
  title = {Postpartum contraception: A matter of guidelines},
  journal = {International Journal of Gynecology & Obstetrics},
  year = {2024},
  doi = {10.1002/ijgo.14928}
}
Kostenlos starten →